PDI 2009 ISDP LAC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Perit Dial Int 26(1): 101-107 2006
© 2006 International Society for Peritoneal Dialysis
This Article
Right arrow Full Text (PDF)
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by van Westrhenen, R.
Right arrow Articles by Hekking, L. H.P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by van Westrhenen, R.
Right arrow Articles by Hekking, L. H.P.

Basic

ALPHA-2-MACROGLOBULIN AND ALBUMIN ARE USEFUL SERUM PROTEINS TO DETECT SUBCLINICAL PERITONITIS IN THE RAT

Roos van Westrhenen1, Wytske M. Westra1, Jacob van den Born2, Raymond T. Krediet1, Eelco D. Keuning2, Johan Hiralall3, Cindy Dragt1 and Liesbeth H.P. Hekking2

Department of Nephrology,1 Academic Medical Center, University of Amsterdam; Department of Molecular Cell Biology and Immunology,2 VU University Medical Center, Amsterdam; Department of Clinical Chemistry,3 Academic Medical Center, University of Amsterdam, The Netherlands

Correspondence to: R. van Westrhenen, Department of Nephrology, F4-215, Academic Medical Center, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands.roosvanw{at}comcast.net

{diamondsuit} Background: In experimental peritoneal dialysis (PD) studies, the occurrence of peritonitis is a confounder in the interpretation of effects of chronic peritoneal exposure to dialysis solutions. Since fluid cannot be drained in most experimental PD models in the rat, it is impossible to diagnose peritonitis based on dialysate white blood cell counts. To study the value of serum markers for the presence of peritonitis, alpha-2-macroglobulin ({alpha}2M) and albumin were measured in rats with and without peritonitis after chronic exposure to dialysis solutions. To further investigate the time course of these markers in relation to the severity of peritonitis, nondialyzed rats were challenged with increasing numbers of bacteria and followed for 28 days.

{diamondsuit} Methods: In the first study, {alpha}2M and albumin were measured in rats exposed to glucose/lactate-based dialysis fluid before sacrifice. A comparison was made between animals with peritonitis, as judged from the presence of extensive infiltrates after sacrifice (gold standard) and/or clinical signs of peritonitis, or absence of peritonitis and infiltrates. In the second study, rats were intraperitoneally (IP) injected with 3 different concentrations of Staphylococcus aureus, and serum {alpha}2M and albumin were measured at various time points.

{diamondsuit} Results: In the first study, serum {alpha}2M was higher and serum albumin was lower in animals with peritonitis compared to animals without peritonitis (both p < 0.05). In the second study, induction of {alpha}2M was clearly dependent on the inoculum concentration. Peak values of {alpha}2M were found at days 1 and 3. At all time points after inoculation, {alpha}2M was higher in all injected groups compared to the control group. Serum albumin values decreased in the highest inoculum group and remained decreased until 28 days after IP injection. Despite a low sensitivity, serum {alpha}2M >40 mg/L and albumin <32 g/L had a specificity of 100% for peritonitis.

{diamondsuit} Conclusions: Measurement of {alpha}2M and albumin once per month is an additional tool in the diagnosis of silent peritonitis in the chronic peritoneal exposure model in the rat. Levels of {alpha}2M >40 mg/L and albumin <32 g/L are strong indicators for peritonitis. However, normal values do not exclude infectious peritonitis.

KEY WORDS: Albumin; alpha-2-macroglobulin; peritonitis; rat model; chronic peritoneal exposure.

Received 3 October 2004; accepted 8 June 2005.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Multimed Inc. logo
Copyright © 2006 by Multimed Inc.